Is TP53 Mutated AML the Same Disease as TP53 Mutated MDS?

被引：0
|
作者：
Valk, Peter J. M. [1 ]
机构：
[1] Univ Med Ctr Rotterdam, Erasmus MC Canc Inst, Dept Hematol, Rotterdam, Netherlands
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2022年 / 22卷
关键词：
AML; MDS-EB; TP53; mutation; outcome; ALLELE FREQUENCY; MUTATIONS; OUTCOMES;
D O I：
10.1016/S2152-2650(22)00640-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S3 / S5
页数：3
相关论文
共 50 条
  • [31] Decitabine in TP53-Mutated AML
    Montalban-Bravo, Guillermo
    Takahashi, Koichi
    Garcia-Manero, Guillermo
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (08): : 796 - 797
  • [32] Halofuginone Exerts Antileukemic Effects in TP53 Mutated Cell Lines
    Candido, Larissa
    Thome, Carol Hassibe
    Silva, Cleide Lucia de Araujo
    Moreno, Daniel Antunes
    Weinhauser, Isabel
    de Almeida, Luciana Yamamoto
    Bonaldo, Camila
    Rego, Eduardo Magalhaes
    Nagler, Arnon
    Pereira-Martins, Diego Antonio
    BLOOD, 2017, 130
  • [33] Expression of wild-type and mutated TP53 in breast carcinomas
    Baumbusch, LO
    Myhre, S
    Langerod, A
    Bergamaschi, A
    Johnsen, H
    Geisler, S
    Lonning, PE
    Borresen-Dale, AL
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S53 - S53
  • [34] Clinicopathologic Features of 73 Patients with TP53 Mutated Multiple Myeloma
    Jelloul, Fatima Zahra
    Shuai, Wen
    Yang, Richard K.
    Fang, Hong
    Patel, Keyur P.
    Medeiros, L. Jeffrey
    Lin, Pei
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S166 - S166
  • [35] TP53 Mutation Characteristics and Their Effects on Overall Survival in AML and MDS
    Puzo, Christian
    Hager, Karl
    Rinder, Henry
    Weinberg, Olga
    Siddon, Alexa
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1468 - S1470
  • [36] TP53 mutations and MDS - not as easy as it seems
    Haase, D.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 7 - 8
  • [37] TP53 binding protein-1 and mutated in Ataxia-Telangiectasia gene variants affect TP53 mutations in lung cancer
    Zienolddiny, S.
    Skaug, V.
    Haugen, A.
    EJC SUPPLEMENTS, 2010, 8 (05): : 225 - 225
  • [38] Isolated TP53 Mutations Portend Worse Prognosis in MDS and AML Compared to TP53 Mutations with Concurrent Myeloid-Associated Mutations
    Hussaini, Mohammad
    Abuel-Haija, Mohammad
    Padron, Eric
    David, Sallman
    Song, Jinming
    MODERN PATHOLOGY, 2018, 31 : 524 - 525
  • [39] Isolated TP53 Mutations Portend Worse Prognosis in MDS and AML Compared to TP53 Mutations with Concurrent Myeloid-Associated Mutations
    Hussaini, Mohammad
    Abuel-Haija, Mohammad
    Padron, Eric
    David, Sallman
    Song, Jinming
    LABORATORY INVESTIGATION, 2018, 98 : 524 - 525
  • [40] TP53, TP53 Target Genes (DRAM, TIGAR), and Autophagy
    Hu, Wanglai
    Chen, Song
    Thorne, Rick F.
    Wu, Mian
    AUTOPHAGY: BIOLOGY AND DISEASES: BASIC SCIENCE, 2019, 1206 : 127 - 149
12345